Atlas Trials

Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer

Clinical trial NCT07346807 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07346807
Sponsor
Shanghai Zhongshan Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Tongue Squamous Cell Carcinoma
Start date
2026-01-01
Primary completion
2026-10-31
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.